CompareMarketResearchRequest a sample
Home / Healthcare / Diabetes Care

Healthcare · Market report

Diabetes Care Market Size, Share and Forecast 2026-2036

The global diabetes care market is worth USD 32.7 bn in 2026 and is forecast to reach USD 77.4 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Continuous glucose monitoring is the largest by product segment.

USD 32.7 bnMarket size 2026
USD 77.4 bnForecast 2036
9.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global diabetes care market is worth USD 32.7 bn in 2026 and is forecast to reach USD 77.4 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Continuous glucose monitoring is the largest by product segment.

ScopeDevices and consumables for managing diabetes: continuous glucose monitors, blood glucose meters and strips, insulin pumps, insulin pens and pen needles, and related software.
IndustryHealthcare
Value 2025USD 30.0 bn
Value 2026USD 32.7 bn
Value 2036USD 77.4 bn
CAGR 2026-20369.0%
Volume 20263,286 million units
Volume 20368,180 million units
Average price 2026USD 9.95 per unit
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Diabetes Care market size and forecast, 2026-2036

Exhibit 1The global diabetes care market is forecast to grow from USD 32.7 bn in 2026 to USD 77.4 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 9.0%
Diabetes Care market value, 2025 to 2036Market value by year. 2025: USD 30.0 bn; 2026: USD 32.7 bn; 2027: USD 35.6 bn; 2028: USD 38.9 bn; 2029: USD 42.3 bn; 2030: USD 46.2 bn; 2031: USD 50.3 bn; 2032: USD 54.8 bn; 2033: USD 59.8 bn; 2034: USD 65.2 bn; 2035: USD 71.0 bn; 2036: USD 77.4 bn. Compound annual growth rate 2026 to 2036: 9.0%.202532.7 bn202650.3 bn203177.4 bn20369.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 32.7 bn
2027USD 35.6 bn
2028USD 38.9 bn
2029USD 42.3 bn
2030USD 46.2 bn
2031USD 50.3 bn
2032USD 54.8 bn
2033USD 59.8 bn
2034USD 65.2 bn
2035USD 71.0 bn
2036USD 77.4 bn

Diabetes Care market segmentation

By product

Exhibit 2Continuous glucose monitoring is the largest segment by product, with 42.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Diabetes Care market share by product, 2026Share of 2026 revenue by product. Continuous glucose monitoring: 42.0%; Insulin pumps and pods: 25.0%; Blood glucose meters and strips: 20.0%; Pen needles and syringes: 8.0%; Software and others: 5.0%.Continuous glucose monitoring42.0%Insulin pumps and pods25.0%Blood glucose meters and strips20.0%Pen needles and syringes8.0%Software and others5.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Continuous glucose monitoring42.0%58.1%USD 13.7 bn12.6%
Insulin pumps and pods25.0%24.2%USD 8.2 bn8.7%
Blood glucose meters and strips20.0%6.1%USD 6.5 bn-3.2%
Pen needles and syringes8.0%4.0%USD 2.6 bn1.7%
Software and others5.0%7.6%USD 1.6 bn13.6%

By type of diabetes

Exhibit 3Type 2 adds the most revenue by type of diabetes, growing from USD 18.3 bn in 2026 to USD 45.4 bn by 2036Estimated revenue in USD by type of diabetes, 2026 and 2036 forecast
Diabetes Care market by type of diabetes, 2026 and 2036Revenue by type of diabetes in 2026 and 2036. Type 2: USD 18.3 bn in 2026, USD 45.4 bn in 2036, change +148%; Type 1: USD 12.4 bn in 2026, USD 26.9 bn in 2036, change +116%; Other and prediabetes: USD 2.0 bn in 2026, USD 5.1 bn in 2036, change +160%.20262036 forecastChangeType 2+148%18.3 bn45.4 bnType 1+116%12.4 bn26.9 bnOther and prediabetes+160%2.0 bn5.1 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Type 138.0%34.7%USD 12.4 bn8.0%
Type 256.0%58.7%USD 18.3 bn9.5%
Other and prediabetes6.0%6.6%USD 2.0 bn10.0%

By device

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Glucose monitoring34.0%38.0%USD 11.1 bn10.2%
Insulin delivery40.0%38.0%USD 13.1 bn8.4%
Consumables and supplies26.0%24.0%USD 8.5 bn8.1%

By channel

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Retail pharmacies42.0%38.0%USD 13.7 bn7.9%
Hospitals20.0%18.0%USD 6.5 bn7.9%
Online and mail order26.0%32.0%USD 8.5 bn11.3%
Direct to patient12.0%12.0%USD 3.9 bn9.0%

By age group

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Adults68.0%66.0%USD 22.2 bn8.7%
Pediatric12.0%14.0%USD 3.9 bn10.7%
Seniors20.0%20.0%USD 6.5 bn9.0%

Top 25 countries for diabetes care by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.0% of 2026 revenue and the 25 countries below together hold 95.1%.

Exhibit 4United States is the largest country market at USD 15.0 bn in 2026, and the three largest countries hold 58.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Diabetes Care market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 15.0 bn, 46.0%; Germany: USD 2.3 bn, 7.0%; Japan: USD 1.6 bn, 5.0%; China: USD 1.6 bn, 5.0%; France: USD 1.3 bn, 4.0%; United Kingdom: USD 1.3 bn, 4.0%; Italy: USD 981 mn, 3.0%; Spain: USD 818 mn, 2.5%; Canada: USD 818 mn, 2.5%; Brazil: USD 654 mn, 2.0%.United States15.0 bn 46.0%Germany2.3 bn 7.0%Japan1.6 bn 5.0%China1.6 bn 5.0%France1.3 bn 4.0%United Kingdom1.3 bn 4.0%Italy981 mn 3.0%Spain818 mn 2.5%Canada818 mn 2.5%Brazil654 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 15.0 bn46.0%USD 35.0 bn8.8%
2GermanyUSD 2.3 bn7.0%USD 5.1 bn8.4%
3JapanUSD 1.6 bn5.0%USD 3.3 bn7.4%
4ChinaUSD 1.6 bn5.0%USD 5.2 bn12.2%
5FranceUSD 1.3 bn4.0%USD 2.9 bn8.4%
6United KingdomUSD 1.3 bn4.0%USD 3.2 bn9.3%
7ItalyUSD 981 mn3.0%USD 2.2 bn8.2%
8SpainUSD 818 mn2.5%USD 1.9 bn9.0%
9CanadaUSD 818 mn2.5%USD 1.9 bn9.0%
10BrazilUSD 654 mn2.0%USD 1.6 bn9.5%
11MexicoUSD 634 mn1.9%USD 1.6 bn9.8%
12IndiaUSD 634 mn1.9%USD 1.6 bn9.8%
13NetherlandsUSD 634 mn1.9%USD 1.4 bn8.5%
14RussiaUSD 500 mn1.5%USD 1.3 bn9.8%
15AustraliaUSD 455 mn1.4%USD 1.0 bn8.6%
16TurkeyUSD 353 mn1.1%USD 898 mn9.8%
17Saudi ArabiaUSD 271 mn0.8%USD 697 mn9.9%
18PolandUSD 229 mn0.7%USD 581 mn9.8%
19ArgentinaUSD 193 mn0.6%USD 488 mn9.7%
20BelgiumUSD 190 mn0.6%USD 434 mn8.6%
21SwedenUSD 147 mn0.5%USD 333 mn8.5%
22ThailandUSD 114 mn0.3%USD 294 mn9.9%
23IndonesiaUSD 95 mn0.3%USD 248 mn10.1%
24AustriaUSD 82 mn0.2%USD 186 mn8.6%
25TaiwanUSD 69 mn0.2%USD 170 mn9.5%
Rest of worldUSD 1.6 bn4.9%USD 3.7 bn8.7%
Exhibit 5United States and China account for 53% of the USD 44.7 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Diabetes Care market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 32.7 bn. United States: +USD 19.9 bn; China: +USD 3.6 bn; Germany: +USD 2.8 bn; United Kingdom: +USD 1.9 bn; Japan: +USD 1.7 bn; 20 other countries: +USD 12.7 bn; Rest of world: +USD 2.1 bn. Market value 2036: USD 77.4 bn.Market value 202632.7 bnUnited States+19.9 bnChina+3.6 bnGermany+2.8 bnUnited Kingdom+1.9 bnJapan+1.7 bn20 other countries+12.7 bnRest of world+2.1 bnMarket value 203677.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Abbott
  • Dexcom
  • Medtronic
  • Insulet
  • Roche
  • Tandem Diabetes Care

Group 2: Regional and specialist players

  • Ascensia Diabetes Care
  • LifeScan
  • Embecta
  • Ypsomed
  • Sinocare
  • i-SENS
  • Dana Diabetes Care
  • Arkray
  • Trividia Health
  • Terumo

Group 3: Emerging and niche players

  • Senseonics
  • Medtrum
  • Biolinq
  • Menarini Diagnostics
  • MicroTech Medical
  • Allez Health

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the diabetes care market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.0% is calculated from the resulting values.

The market is divided by product, by type of diabetes, by device, by channel, by age group. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the diabetes care market?

The global diabetes care market is estimated at USD 30.0 bn in 2025 and USD 32.7 bn in 2026.

How fast will the diabetes care market grow?

It is forecast to reach USD 77.4 bn by 2036, a compound annual growth rate of 9.0% from 2026, an increase of USD 44.7 bn.

Which country is the largest market for diabetes care?

United States is the largest market by revenue at USD 15.0 bn in 2026, 46.0% of the global total. The three largest countries together hold 58.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 12.2% a year from 2026 to 2036.

Which diabetes care segment is largest?

In the by product split, Continuous glucose monitoring is the largest segment with 42.0% of 2026 revenue.

Who are the leading diabetes care companies?

Global leaders include Abbott, Dexcom, Medtronic, Insulet.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Dermatology Cryosurgery Units Diabetes Drugs →

All Healthcare markets →

Request a sample